Actively Recruiting
European Survey of Cardiovascular Disease Prevention, Diabetes and Chronic Kidney Disease
Led by European Society of Cardiology · Updated on 2024-07-10
8000
Participants Needed
1
Research Sites
226 weeks
Total Duration
On this page
Sponsors
E
European Society of Cardiology
Lead Sponsor
N
National Institute for Prevention and Cardiovascular Health, Ireland
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to provide a comprehensive European overview of preventive care practices by cardiologists, specialists, and primary care physicians for patients with coronary heart disease (CHD), individuals at high risk of cardiovascular disease, and those with conditions like hypertension, dyslipidaemia, diabetes, and chronic kidney disease. It evaluates whether current European guidelines on cardiovascular disease prevention and management of related conditions are being followed. This is the sixth survey in a series conducted by the European Society of Cardiology to assess clinical practice across multiple countries. The study is observational and includes two main groups: patients who have experienced coronary heart disease events and individuals at high risk of cardiovascular disease in primary care. It will investigate management through lifestyle and drug therapies, focusing on hospital patients with CHD and apparently healthy high-risk individuals in primary care. The survey will be conducted from 2023 to 2025, continuing the ongoing effort to track cardiometabolic and renal health in Europe. Participants will be followed over a 30-month period to measure how many meet European targets for lifestyle, risk factors, and therapeutic goals for cardiovascular disease prevention. The study involves collecting data on clinical management and patient health status without administering treatments. Researchers will assess adherence to guidelines and risk management practices, helping to identify areas for improvement in preventing cardiovascular disease. The total participation time per individual varies based on the timing of their index event and follow-up assessments.
CONDITIONS
Brief Title
European Survey of Cardiovascular Disease Prevention, Diabetes and Chronic Kidney Disease (EUROASPIRE VI)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older at the time of identification
- Patients who have signed an informed consent
- At least six and at most 24 months have passed since the index event
- Coronary patients with acute coronary events (STEMI, NSTEMI, unstable angina) or coronary revascularisation (CABG, PCI)
- High cardiovascular disease risk patients prescribed blood pressure, lipid-lowering, or glucose-lowering treatments without existing cardiovascular disease
You will not qualify if you...
- Patients living outside the defined geographical areas
- Patients admitted from outside the geographical area or treated in non-participating hospitals
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 30 months
Participants who undergo routine care are observed for cardiovascular risk factors, lifestyle, and use of drug therapies.
1 to 2 visits depending on participant group and assessments
Trial Site Locations
Total: 1 location
1
Istanbul University, Cerrahpaşa Cardiology Institute
Istanbul, Turkey (Türkiye)
Actively Recruiting
Research Team
E
Emilie Soriano
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here